Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen

Environmental and Molecular Mutagenesis

Volumn 32, Issue 3, 1998, Pages 236-243

  Meng, Quanxin ^a,b   Skopek, Thomas R ^c   Walker, Dale M ^a   Hurley Leslie, Shellene ^a   Chen, Tao ^d   Zimmer, David M ^e   Walker, Vernon E ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^e PFIZER INC   (United States)

Author keywords

Cloning efficiency; Concanavalin A; Hprt; Lymphocytes; Mouse; Propagation

Indexed keywords

CONCANAVALIN A; IONOMYCIN; PHORBOL 12 ACETATE 13 MYRISTATE; PHYTOHEMAGGLUTININ;

ARTICLE; CELL MUTANT; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MITOGENESIS; MUTATION; T LYMPHOCYTE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; CONCANAVALIN A; CULTURE MEDIA; EVALUATION STUDIES; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IONOMYCIN; MICE; MUTATION; PHYTOHEMAGGLUTININS; SPLEEN; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0031798094     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)32:3<236::AID-EM6>3.0.CO;2-Y     Document Type: Article

References (42)

1. Albert F, Hua C, Truneh A, Pierres M, Schmitt-Verhulst AM (1985): Distinction between antigen receptor and IL-2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester. J Immunol 134:3649-3655.
2. Beare DM, Aldridge KE, O'Donovan MR, Cole J (1993): An improved procedure for the in vitro expansion of human T-lymphocyte clones for mutant analysis. Mutat Res 291:207-212.
3. Chen T, Aidoo A, Casciano DA, Heflich RH (1998): Expansion of rat 6-thioguanine-resistant T-lymphocyte clones by stimulation with ionomycin and a phorbol ester. Environ Mol Mutagen 31:97-102.
4. Cochrane JE, Skopek TR (1994): Mutagenicity of butadiene and its epoxide metabolites. II. Mutational spectrum of butadiene, 1,2-epoxybutene and diepoxybutane at the Hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15:719-723.
5. Dempsey JL, Morley AA (1986): Measurement of in vivo mutant frequency in lymphocytes in the mouse. Environ Mutagen 8:385-391.
6. Fleischer B (1983): Activation of human T-lymphocytes. I. Requirements for mitogen-induced proliferation of antigen-specific T-lymphocytes clones. Eur J Immunol 13:970-976.
7. Fleischer B (1988): Non-specific propagation of human antigen-dependent T-lymphocyte clones. J Immunol Methods 163:215-219.
8. Gullberg M, Smith KA (1986): Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2. J Exp Med 163:270-284.
9. Hemler ME, Brenner MB, McLean JM, Strominger JL (1984): Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells. Proc Natl Acad Sci USA 81:2172-2175.
10. Jones IM, Burkhart-Schultz K, Strout CL, Carrano AV (1985a): A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat Res 147:97-105.
11. Jones IM, Burkhart-Schultz K, Strout CL, Carrano AV (1985b): A study of the frequency of sister-chromatid exchange and of thiogua- nine-resistant cells in mouse spleen lymphocytes after in vivo exposures to ethylnitrosourea. Mutat Res 143:245-249.
12. Jones IM, Burkhart-Schultz K, Strout CL, Crippen TL (1987a): Factors that affect the frequency of thioguanine-resistant lymphocytes in mice following exposure to ethylnitrosourea. Environ Mutagen 9:317-329.
13. Jones IM, Burkhart-Schultz K, Strout CL, Crippen TL (1987b): Cloned mouse lymphocytes permit analysis of somatic mutations that occur in vivo. Somat Cell Mol Genet 13:325-333.
14. Ledbetter JA, Herzenberg (1978): Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63-90.
15. Lugo JP, Krishnan SN, Sailor RD, Rothenberg EV (1986): Early precursor thymocytes can produce interleukin 2 upon stimulation with calcium ionophore and phorbol ester. Proc Natl Acad Sci USA 83:1862-1866.
16. Meng Q, Recio L, Reilly AA, Wong B, Bauer B, Walker VE (1998a): Comparison of the mutagenic potency of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats. Carcinogenesis 19:1019-27.
17. Meng Q, Henderson RF, Reilly AA, Bauer M, Walker VE (1998b): Relative contribution of epoxybutene versus diepoxybutane to the mutagenicity of butadiene following inhalation exposures of mice and rats. Cancer Res, submitted.
18. Meuer SC, Acuto O, Hercend T, Schlossman SF, Reinherz EL (1984): The human T-cell receptor. Annu Rev Immunol 2:23-50.
19. Mills GB, Cheung RK, Grinstein S, Gelfand EW (1985): Increase in cytosolic free calcium concentration is an intracellular messenger for the production of interleukin 2 but not for expression of the interleukin 2 receptor. J Immunol 134:1640-1643.
20. Mittelstaedt RA, Heflich RH (1994): Analysis of in vivo mutation in exon 8 of the rat Hprt gene. Mutat Res 311:139-148.
21. Mittelstaedt RA, Smith B A, Heflich RH (1995): Analysis of in vivo mutation induced by N-ethyl-N-nitrosourea in the Hprt gene of rat lymphocytes. Environ Mol Mutagen 26:261-269.
22. Olivero OA, Anderson LM, Bhalchandra AD, Haines DC, Harbaugh SW, Moskal TJ, Jones AB, Rice JM, Riggs CW, Logsdon D, Yuspa SH, Poirier MC (1997): Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): Tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst 89:1602-1608.
23. O'Neill JP, McGinniss MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ (1987): Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2:87-94.
24. Sharon N (1983): Lectin receptors as lymphocyte surface marker. Adv Immunol 34:213-298.
25. Skopek TR, Walker VE, Cochrane JE, Craft TR, Cariello NF (1992): Mutational spectrum of N-ethyl-N-nitrosourea at the Hprt locus in splenic T-cells of exposed B6C3F1 mice. Proc Natl Acad Sci USA 89:7866-7870.
26. Skopek, TR, Kort KL, Marino DR (1995): Relative sensitivity of the endogenous Hprt gene and lacI transgene in ENU-treated Big Blue™ mice. Environ Mol Mutagen 26:9-15.
27. Skopek, TR, Kort KL, Marino DR, Mittal LV, Umbenhauer DR, Laws GM, Adams SP (1996): Mutagenic response of the endogenous Hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue® mice. Environ Mol Mutagen 28:376-384.
28. Sussman HE, Walker VE (1998): Mutagenicity of AZT in the human lymphoblastoid cell line, TK6. J Acquir Immune Defic Syndr 17(4):A35.
29. Tan RS, Chu EHY, Sinsheimer JE (1993): Molecular analysis of hypoxanthine phosphoribosyl transferase mutants induced by glycidyl 1-naphthyl ether in mouse spleen cells in vivo. Environ Mol Mutagen 22:71-77.
30. Tates AD, van Dam FJ, de Zwart FA, van Teylingen CMM, Natarajan AT (1994): Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene. Mutat Res 309:299-306.
31. Tates AD, van Dam FJ, van Teylingen CMM, de Zwart FA, Zwinderman AH (1998): Comparison of induction of Hprt mutations by 1,3-butadiene and/or its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo. Mutat Res 397:21-36.
32. Truneh A, Albert F, Golstein P, Schmitt-Verhulst AM (1985a): Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318-320.
33. Truneh A, Albert F, Golstein P, Schmitt-Verhulst AM (1985b): Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolic T-lymphocytes from specifically primed precursors. J Immunol 135:2262-2267.
34. Walker VE, Lutze-Mann L (1998): Mutagenicity of high LET-irradiation at the endogenous Hprt gene and the lacZ transgene of exposed mice with differing p53 status. Proc Am Assoc Cancer Res 39:126.
35. Walker VE, Skopek TR (1993): A mouse model for the study of in vivo mutational spectra: Sequence specificity of ethylene oxide at the Hprt locus. Mutat Res 288:151-162.
36. Walker VE, Walker DM (1997): Mutagenicity at the Hprt locus of T-cells following drinking water exposures of F344 rats to acrylonitrile. Toxicologist 36:308.
37. Walker VE, Gorelick NJ, Andrews JL, Craft TR, deBoer JG, Glickman BW (1996): Frequency and spectrum of ethylnitrosourea-induced mutation at the Hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res 56:4654-4661.
38. Walker VE, Sisk SC, Upton PB, Wong BA, Recio L (1997): In vivo mutagenicity of ethylene oxide at the Hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat Res 392:211-222.
39. Walker VE, Andrews JL, Clement NL, Upton PB, deBoer JG, Sussman HE, Gorelick NJ (1998a): Detection of cylophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice. Cancer Res, submitted.
40. Walker VE, Meng Q, Clement NL, Heflich RH, Upton PB, Swenberg JA, Skopek, TR (1998b): Mutagenicity at the Hprt locus of lymphocytes from mice and rats exposed by inhalation to ethylene or ethylene oxide. Cancer Res, submitted.
41. Walker VE, Craft TR, Clement NL, Skopek TR (1998c): In vivo mutagenicity at the Hprt locus in splenic lymphocytes of B6C3F1 mice following parenteral exposures to ethylene oxide. Carcinogenesis, submitted.
42. Weiss A, Imboden J, Shoback D, Stobo J (1984): Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc Natl Acad Sci USA 81:4169-4173.